Alexion Pharmaceuticals, Inc.

Grantham, Mayo, Van Otterloo & Co. LLC ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/12/2021

Shares

528,033

Value ($000)

97,005

Weight

0.5%

2020 Q4 - 2021 Q2 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/12/2021	97,005	0.5%	528,033	6/30/2021
2021 Q1	5/13/2021	102,346	0.6%	669,323	3/31/2021
2020 Q4	2/12/2021	42,479	0.3%	271,883	12/31/2020